Thyrotropin

DB15263Investigational

Thyrotropin is a medication indicated in thyroid stimulation before radioactive iodine ablation or for thyroid imaging. Thyrotropin is under investigation in clinical trial NCT01348191 (Detection of Thyrotrophin Receptor in Human Myometrium).

Mechanism: Pharmacologically active on Thyrotropin receptor
Curator reviewed
Also known as: THYROTROPHIN

Resolves to

Compound

UNII02KSI6Z9AKCAS9002-71-5

Clinical / RWD

RxNorm10579ATCV04CJ01

Targets

P16473TSHR

What you can answer from here — as of June 15, 2026

1Protein targetEach mapped to UniProt, with action and pharmacological action

Listed above

222Drug interactionsStructured to mechanism, not free text

3Clinical trialsPhase, status and sponsor resolved per trial

2Structured indicationsCondition, population, route and combination as fields, not prose

2ContraindicationsEach with its own population and attribute set

3Marketed productsAcross 2 countries and 2 labellers

1ATC codeIncluding every combination product, plus 10 drug categories

3+ReferencesStructured and connected to the statements they support

Which drugs share a target with Thyrotropin, and which of those have an active Phase 3 trial?

Answer this in Biopharma OS Sign in to your account

Create a free account or log in to explore the full data card.

Create Account